Characterization of a novel antibacterial agent that inhibits bacterial translation

Bacterial protein synthesis is the target for several classes of established antibiotics. This report describes the characterization of a novel translation inhibitor produced by the soil bacterium Flexibacter. The dipeptide antibiotic TAN1057 A/B was synthesized and designated GS7128. As reported pr...

Full description

Saved in:
Bibliographic Details
Published inRNA (Cambridge) Vol. 8; no. 9; pp. 1120 - 1128
Main Authors BÖDDEKER, NINA, BAHADOR, GINA, GIBBS, CRAIG, MABERY, ERIC, WOLF, JOHN, XU, LIANHONG, WATSON, JULIA
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.09.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bacterial protein synthesis is the target for several classes of established antibiotics. This report describes the characterization of a novel translation inhibitor produced by the soil bacterium Flexibacter. The dipeptide antibiotic TAN1057 A/B was synthesized and designated GS7128. As reported previously, TAN1057 inhibits protein synthesis in both Escherichia coli and Staphylococcus aureus, leaving transcription unaffected. Cell-free translation systems from E. coli were used to further dissect the mechanism of translational inhibition. Binding of mRNA to ribosomes was unaffected by the drug, whereas the initiation reaction was reduced. Elongation of translation was completely inhibited by GS7128. Detailed analysis showed that the peptidyl transferase reaction was strongly inhibited, whereas tRNA binding to both A- and P-site was unaffected. Selection and analysis of drug-resistant mutants of S. aureus suggests that drug uptake may be mediated by a dipeptide transport mechanism.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1355-8382
1469-9001
DOI:10.1017/S1355838202024020